Companies / Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.

Nasdaq: VRDNCIK 1590750WALTHAM, MA

Financials · FY2017

Revenue$4.00M
Net income$-342.60M
Total debt$20.89M
Cash$24.86M
Diluted EPS$-5.31
Shares outstanding113.3M

Ownership

113.3M shares outstanding · as of Aug 3, 2026
0.05%Insiders
Ownership
Insiders0.05%57,636
10%+ / strategic8.93%10,120,350
Institutions89.92%101,875,279
Public float1.09%1,239,004

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Mahoney Stephen F.CEOPresident and CEO · Director
0.03%33,130
Beetham Thomas W.Chief Operating Officer
0.01%13,271
Harmon SethChief Financial Officer
<0.01%7,790
Tousignant JenniferChief Legal Officer
<0.01%3,445
Tripuraneni RadhikaChief Medical Officer

Institutional holders 238

View all →
HolderValue% of shares
Fmr LLC$447.64M12.70%
Vanguard Group Inc$174.65M4.95%
BlackRock, Inc.$157.09M7.55%
Bellevue Group AG$135.64M3.85%
Fairmount Funds Management LLC$121.82M3.46%
VR Adviser, LLC$120.83M3.43%
State Street Corporation$112.52M5.41%
Deep Track Capital, LP$78.57M2.23%
Wellington Management Group LLP$61.35M1.74%
Eversept Partners, LP$55.46M1.57%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 3, 2026Mahoney Stephen F.
CEO
OtherCommon Stock$223.6K-7K
-18.18%
33,349
0.03% of shares
low
Mar 3, 2026Mahoney Stephen F.
CEO
OtherCommon Stock$223.6K-8K
-18.71%
33,130
0.03% of shares
low
Mar 3, 2026Beetham Thomas W.
Executive
OtherCommon Stock$92.0K-3K
-18.58%
13,361
0.01% of shares
low
Mar 3, 2026Beetham Thomas W.
Executive
OtherCommon Stock$92.0K-3K
-19.12%
13,271
0.01% of shares
low
Dec 31, 2025Tousignant Jennifer
Executive
SellCommon Stock$70.8K-2K
-100.00%
0
0.00% of shares
low
Mar 3, 2026Harmon Seth
Executive
OtherCommon Stock$61.3K-2K
-20.55%
7,850
<0.01% of shares
low
Mar 3, 2026Harmon Seth
Executive
OtherCommon Stock$61.3K-2K
-21.16%
7,790
<0.01% of shares
low
Mar 3, 2026Tousignant Jennifer
Executive
OtherCommon Stock$50.6K-2K
-32.40%
3,494
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G6,124,976
Vanguard Group IncPassive13G/A0
Deep Track Capital, LPPassive13G/A2,524,833
Kynam Capital Management, LPPassive13G/A1,470,541

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VRDN92790C104